Donate

Latest news & articles

Latest news
Vale Professor Helen Thomas, type 1 diabetes research pioneer
Research

Vale Professor Helen Thomas, type 1 diabetes research pioneer

It is with heavy hearts that JDRF Australia and Breakthrough T1D farewell Professor Helen Thomas following her recent passing. Professor Thomas was a great in the world of type 1 diabetes (T1D) research and collaborator on many of T1D research projects across Australia. She was a recognised international leader who made significant advancements in the […]
Apply now for JDRF’s Career Support and Travel Grant
Research

Apply now for JDRF’s Career Support and Travel Grant

JDRF Australia is proud to announce that the next round of Career Support and Travel Grants is now open.   JDRF Australia aims to support the next generation of type 1 diabetes (T1D) researchers by helping them with skills development or facilitating them to present and attend scientific conferences. This enables them to gain new skills, […]
Supporting the next generation of type 1 diabetes scientists
Research

Supporting the next generation of type 1 diabetes scientists

JDRF Australia is committed to a vision of a world without type 1 diabetes (T1D) through funding the best science. But research can only be done by researchers. This is why we have a strong focus on not only funding established researchers but also investing in the development of those earlier on in their career […]
New clinical trial looking for Queensland adults with type 1 diabetes
Research

New clinical trial looking for Queensland adults with type 1 diabetes

A new trial called the ASITI-201 Study is looking for participants based in Queensland to test a potential new therapy for type 1 diabetes (T1D). The therapy is designed to stop the immune system attack that characterises the condition.  T1D is an autoimmune condition where the immune system mistakenly attacks the insulin-producing beta cells of […]
Preschool-aged children in early-stage type 1 diabetes have changes in blood sugar levels, even before they are officially diagnosed
Research

Preschool-aged children in early-stage type 1 diabetes have changes in blood sugar levels, even before they are officially diagnosed

New research has found that preschoolers who are in the early, pre-symptomatic stages of type 1 diabetes (T1D) have changes in blood sugar levels well before symptoms appear. We used to think that people developed T1D when they first showed the ‘4T’ symptoms: thirst, tiredness, toilet (increased urination) and thin (weight loss). This is when […]
New clinical trial looking for participants to test semaglutide in type 1 diabetes
Research

New clinical trial looking for participants to test semaglutide in type 1 diabetes

A new clinical trial investigating the use of semaglutide for type 1 diabetes (T1D) has launched in Sydney and is actively recruiting. The trial, called REducing Cardiometabolic Risk with SEmaglutide in Type 1 diabetes (The RESET1 study) is looking for adults to test whether semaglutide, a medication currently used to treat type 2 diabetes, can […]
Australian researchers set to develop new insulin formulation which could transform type 1 diabetes management
Research

Australian researchers set to develop new insulin formulation which could transform type 1 diabetes management

Australian researcher Professor Christoph Hagemeyer from Monash University and colleagues have received over $750,000 to take their innovative new insulin formulation to the next stage of research.  In people with type 1 diabetes (T1D), the immune system incorrectly attacks the cells of the pancreas that normally produce insulin, a hormone essential to regulate blood sugar […]
New guidance set to change the way we diagnose type 1 diabetes
Research

New guidance set to change the way we diagnose type 1 diabetes

Screening and monitoring will bring forward diagnoses and make early detection of the condition a reality Type 1 diabetes (T1D) diagnoses could soon be transformed with newly released guidance outlining how to detect and monitor early-stage T1D, before the point of symptom onset. The chronic autoimmune condition is traditionally diagnosed when elevated blood glucose levels […]
The T1D canary – looking at islet autoantibodies to predict the progression to symptomatic type 1 diabetes 
Research

The T1D canary – looking at islet autoantibodies to predict the progression to symptomatic type 1 diabetes 

A new study has added to the evidence that people develop type 1 diabetes (T1D) at different rates, and that a blood test can predict when this may occur  We used to think that people only developed T1D when they showed the ‘4T symptoms’: thirst, tiredness, toilet (increased urination) and thin (weigh loss). And while […]
Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn Fellowship
Research

Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn Fellowship

Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn EMCR Fellowship JDRF Australia is happy to announce that three promising researchers will be supported under the Tim Welborn Early-to-Mid Career Research (EMCR) Fellowship for basic research. This award funds the next generation of type 1 diabetes (T1D) researchers to ensure their career development is […]
$3M invested for researchers working towards precision medicine for type 1 diabetes
News

$3M invested for researchers working towards precision medicine for type 1 diabetes

JDRF Australia and JDRF International have announced over $3m AUD in funding for researchers aiming to improve health outcomes for the type 1 diabetes (T1D) community by making precision medicine possible.   Precision medicine has delivered great benefits in other disease areas, such as cancer, and involves treatment that is tailored to a person’s genes, environment, […]
Australian researcher internationally recognised for achievements in type 1 diabetes screening
Research

Australian researcher internationally recognised for achievements in type 1 diabetes screening

We are proud to announce that Dr Kirstine Bell from the Charles Perkins Centre at The University of Sydney has been awarded the 2023 JDRF Dr Robert Goldstein Award for her notable contributions to type 1 diabetes (T1D) research. This is an internationally competitive award given to early career researchers who show great promise in […]
Funding to characterise a new target for type 1 diabetes prevention
Research

Funding to characterise a new target for type 1 diabetes prevention

JDRF is proud to announce new funding of $200,000 (USD) to Dr Irina Buckle from Mater Research and The University of Queensland, to undertake a project which aims to understand what may be driving type 1 diabetes.   Type 1 Diabetes (T1D) is a condition where certain types of immune cells, known as T cells, incorrectly […]
New formulation of insulin may speed up its action for people with type 1 diabetes
Research

New formulation of insulin may speed up its action for people with type 1 diabetes

A research group from Norway has found that adding small amounts of glucagon to insulin speeds up its action. For people with type 1 diabetes (T1D) this would mean a faster acting insulin than what is on the market, and in turn, improved quality of life.    The need for fast insulin T1D is an autoimmune […]
New support for Australia’s best and brightest early career researchers
Research

New support for Australia’s best and brightest early career researchers

JDRF is delighted to announce that three Australian Early to Mid-Career Researchers (EMCRs) are being supported with over $2.2 million to continue their groundbreaking type 1 diabetes (T1D) research.   JDRF is committed to nurturing the growth and impact of leading independent researchers who are instrumental in translating scientific discoveries to clinical applications.  Dr Aveni Haynes […]
JDRF supports a medical corridor in the Middle East
Research

JDRF supports a medical corridor in the Middle East

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times […]
$3 million invested to understand and prevent the development of T1D
Research

$3 million invested to understand and prevent the development of T1D

JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) have committed $3 million for research projects aimed at understanding how type 1 diabetes (T1D) develops, with the ultimate goal of preventing it. This is in collaboration with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. ENDIA is the world’s first T1D observational […]
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
Research

Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]